Investments Pharmaceutical Profit and Loss 
CFO News Room
NOVEMBER 13, 2022
related investing news. after the company reported a smaller-than-expected quarterly loss and said its production would remain on track despite supply chain snafus. AstraZeneca – The pharmaceutical company added 6.6% after it raised full-year profits, pointing to strong sales among its cancer drugs. from 14.9%.
Musings on Markets
FEBRUARY 16, 2024
He suggested Blue Lagoon, a well-regarded Icelandic Spa with a history of profitability, that was finding its existence under threat, as a result of volcanic activity in Southwest Iceland. The market capitalization of many young pharmaceutical company have been wiped out by the failure of blockbuster drug, in trials.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Musings on Markets
OCTOBER 28, 2024
What do corporate venture capital (CVC), sovereign wealth funds (SWF) and green investing share in common? Corporate Venture Capital Corporate venture capital (CVC) refers to capital invested by established firms, into young companies and start-ups, sometimes in the same business and sometimes in others.
Musings on Markets
DECEMBER 10, 2023
We will end with a discussion of how enterprises try, with mixed effects, to build protections against the loss of key personnel. We will then follow up with a framework for thinking about how key people can affect the value of a business, with practical suggestions on valuing and pricing key people. Who is a key person?
PYMNTS
SEPTEMBER 19, 2018
Spending on cognitive and artificial intelligence (AI) systems is expected to see continued strong growth as businesses invest in projects in those areas. Two areas of focus for the investments include conversational AI applications and deep learning and machine learning applications. billion in 2022, more than three times the $24.0
PYMNTS
MAY 13, 2019
Shares in African eCommerce company Jumia Technologies took a dive on Monday (May 13) after Q1 losses were reported to be bigger than the year before, according to a report from Bloomberg. The firm became well-known after it targeted Valeant , a pharmaceutical firm. The company’s Q1 operating losses increased to 45.5
Musings on Markets
OCTOBER 6, 2023
The Rise of Intangibles While the debate about intangibles, and how best to value them, is relatively recent, it is unquestionable that intangibles have been a part of valuation, and the investment process, through history. With that said, it is clear that the debate about intangibles has become more intense in the last two decades.
Expert insights. Personalized for you.
130 
Let's personalize your content